Literature DB >> 24867773

Peri-procedural management of anti-platelets and anticoagulation in patients undergoing MitraClip procedure.

Said Alsidawi1, Mohamad Effat.   

Abstract

The MitraClip device was recently approved by the FDA for the management of severe degenerative mitral regurgitation in patients considered to be high risk for surgical repair or replacement of the mitral valve. The management of anti-platelet and anticoagulant therapy before, during, and after the MitraClip placement is not well defined given the lack of evidence from large randomized trials. In this paper, we propose practical management guidelines for using these agents.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24867773     DOI： 10.1007/s11239-014-1092-3

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


  10 in total

1.  Introduction to the ninth edition: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Gordon H Guyatt; Elie A Akl; Mark Crowther; Holger J Schünemann; David D Gutterman; Sandra Zelman Lewis
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial.

Authors:  Ted Feldman; Hal S Wasserman; Howard C Herrmann; William Gray; Peter C Block; Patrick Whitlow; Fred St Goar; Leonardo Rodriguez; Frank Silvestry; Allan Schwartz; Timothy A Sanborn; Jose A Condado; Elyse Foster
Journal:  J Am Coll Cardiol       Date:  2005-10-19       Impact factor: 24.094

3.  Large atrial thrombus formation after MitraClip implantation: is anticoagulation mandatory?

Authors:  Raffi Bekeredjian; Derliz Mereles; Sven Pleger; Ulrike Krumsdorf; Hugo A Katus; Wolfgang Rottbauer
Journal:  J Heart Valve Dis       Date:  2011-03

4.  The EVEREST II Trial: design and rationale for a randomized study of the evalve mitraclip system compared with mitral valve surgery for mitral regurgitation.

Authors:  Laura Mauri; Pallav Garg; Joseph M Massaro; Elyse Foster; Donald Glower; Paul Mehoudar; Ferolyn Powell; Jan Komtebedde; Elizabeth McDermott; Ted Feldman
Journal:  Am Heart J       Date:  2010-07       Impact factor: 4.749

5.  Acute outcomes of MitraClip therapy for mitral regurgitation in high-surgical-risk patients: emphasis on adverse valve morphology and severe left ventricular dysfunction.

Authors:  Olaf Franzen; Stephan Baldus; Volker Rudolph; Sven Meyer; Malgorzata Knap; Dietmar Koschyk; Hendrik Treede; Achim Barmeyer; Joachim Schofer; Angelika Costard-Jäckle; Michael Schlüter; Hermann Reichenspurner; Thomas Meinertz
Journal:  Eur Heart J       Date:  2010-03-10       Impact factor: 29.983

6.  Stroke and thrombus formation appending to the MitraClip: what is the appropriate anticoagulation regimen?

Authors:  Karsten Hamm; Sebastian Barth; Anno Diegeler; Sebastian Kerber
Journal:  J Heart Valve Dis       Date:  2013-09

7.  Percutaneous repair or surgery for mitral regurgitation.

Authors:  Ted Feldman; Elyse Foster; Donald D Glower; Donald G Glower; Saibal Kar; Michael J Rinaldi; Peter S Fail; Richard W Smalling; Robert Siegel; Geoffrey A Rose; Eric Engeron; Catalin Loghin; Alfredo Trento; Eric R Skipper; Tommy Fudge; George V Letsou; Joseph M Massaro; Laura Mauri
Journal:  N Engl J Med       Date:  2011-04-04       Impact factor: 91.245

8.  Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study.

Authors:  Patrick L Whitlow; Ted Feldman; Wes R Pedersen; D Scott Lim; Robert Kipperman; Richard Smalling; Tanvir Bajwa; Howard C Herrmann; John Lasala; James T Maddux; Murat Tuzcu; Samir Kapadia; Alfredo Trento; Robert J Siegel; Elyse Foster; Donald Glower; Laura Mauri; Saibal Kar
Journal:  J Am Coll Cardiol       Date:  2012-01-10       Impact factor: 24.094

9.  Bivalirudin for patients with acute coronary syndromes.

Authors:  Gregg W Stone; Brent T McLaurin; David A Cox; Michel E Bertrand; A Michael Lincoff; Jeffrey W Moses; Harvey D White; Stuart J Pocock; James H Ware; Frederick Feit; Antonio Colombo; Philip E Aylward; Angel R Cequier; Harald Darius; Walter Desmet; Ramin Ebrahimi; Martial Hamon; Lars H Rasmussen; Hans-Jürgen Rupprecht; James Hoekstra; Roxana Mehran; E Magnus Ohman
Journal:  N Engl J Med       Date:  2006-11-23       Impact factor: 91.245

10.  Bivalirudin during primary PCI in acute myocardial infarction.

Authors:  Gregg W Stone; Bernhard Witzenbichler; Giulio Guagliumi; Jan Z Peruga; Bruce R Brodie; Dariusz Dudek; Ran Kornowski; Franz Hartmann; Bernard J Gersh; Stuart J Pocock; George Dangas; S Chiu Wong; Ajay J Kirtane; Helen Parise; Roxana Mehran
Journal:  N Engl J Med       Date:  2008-05-22       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.